1. Home
  2. CSBR vs NUKK Comparison

CSBR vs NUKK Comparison

Compare CSBR & NUKK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Champions Oncology Inc.

CSBR

Champions Oncology Inc.

HOLD

Current Price

$6.59

Market Cap

90.0M

Sector

Health Care

ML Signal

HOLD

Logo Nukkleus Inc.

NUKK

Nukkleus Inc.

HOLD

Current Price

$3.77

Market Cap

67.9M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSBR
NUKK
Founded
1985
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Blank Checks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
90.0M
67.9M
IPO Year
1986
N/A

Fundamental Metrics

Financial Performance
Metric
CSBR
NUKK
Price
$6.59
$3.77
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$12.00
N/A
AVG Volume (30 Days)
21.8K
897.7K
Earning Date
12-15-2025
02-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.17
N/A
Revenue
$58,424,000.00
N/A
Revenue This Year
$4.84
N/A
Revenue Next Year
$11.51
N/A
P/E Ratio
$38.68
N/A
Revenue Growth
9.06
N/A
52 Week Low
$5.59
$3.31
52 Week High
$11.99
$39.85

Technical Indicators

Market Signals
Indicator
CSBR
NUKK
Relative Strength Index (RSI) 50.08 36.43
Support Level $6.52 $3.89
Resistance Level $6.79 $4.32
Average True Range (ATR) 0.37 0.40
MACD -0.03 -0.05
Stochastic Oscillator 46.22 19.15

Price Performance

Historical Comparison
CSBR
NUKK

About CSBR Champions Oncology Inc.

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

About NUKK Nukkleus Inc.

Nukkleus Inc is a financial technology company that is focused on providing software and technology solutions. The company's operating segment includes General support services and Financial services. General support services include providing software, technology, customer sales and marketing, and risk management technology hardware and software solutions package under a GSA to a related party. Financial services include providing payment services from one fiat currency to another or to digital assets. It generates maximum revenue from the General support services segment. Geographically operates in USA, UK and Malta, with majority of revenue from United Kingdom (UK).

Share on Social Networks: